Sensitivity analysis confirmed the robustness of these rankings, showing that Avidite Base Chemistry consistently performed well even with varying criteria weights.

The results of the study urge stakeholders to consider these rankings, particularly in critical health scenarios such as pandemics, where the choice of technology can significantly impact outcomes.

Genome sequencing technologies play a crucial role in characterizing microorganisms, identifying mutations, and enhancing patient management in infectious diseases.

The rapid detection of pathogens is essential for reducing mortality rates and improving treatment outcomes, prompting the development of advanced genome sequencing techniques since 1977.

A recent analysis evaluated fifteen advanced sequencing techniques, including Avidite Base Chemistry, Nanopore, and Illumina systems, based on criteria such as accuracy, cost, and processing time.

Infectious diseases are a major global health concern, accounting for 13.7 million deaths in 2019, which underscores the urgent need for effective diagnostic technologies.

This systematic approach to decision-making enables healthcare decision-makers and researchers to make informed choices when selecting sequencing technologies.

The study's findings ranked Avidite Base Chemistry as the most effective sequencing technology, followed by Oxford Nanopore and Illumina, highlighting their relative strengths in various applications.

Fuzzy PROMETHEE, a specific Multi-Criteria Decision-Making (MCDM) method, was employed to incorporate fuzzy logic, allowing for a nuanced evaluation of sequencing technologies.